Replies to post #206841 on Biotech Values

[RNsidersbuying]

TNXP .414 - had what I thought was a super pr. Noted several catalysts upcoming with the main one being a Phase3 commencement in Q1. Could TNXP possibly get some national exposure with the reference to veteran's PTSD. Also a recent 13-G filing from Rosalind Capital Partners L.P. and still has roughly $.70 hardcash remaining at Q3 filing.

Would love to hear your feedback on this one?

[masterlongevity]

soluble abeta can show up in plasma abeta, meaning LLY can show a difference. PET scans only measure insoluble plaques. thats why they didnt show anything on PET and $Biib did. The $Biib antibody more similar to Bapineuzumab or Gantenerumab in that it is more focused on amyloid fibrils and plaque